Boda Z

No ORCID on file · 2 papers in corpus · active 2024-2025
2025
Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease.
AJOG global reports ·doi:10.1016/j.xagr.2025.100501

BackgroundHeavy menstrual bleeding is the dominant symptom in girls/women with von Willebrand disease (VWD), affecting ∼80 to 90%. Female patients with VWD are typically diagnosed later than males, despite the disproportionate impact of hea…

2024
Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
International journal of molecular sciences ·doi:10.3390/ijms25052893

Antithrombin (AT) is the major plasma inhibitor of thrombin (FIIa) and activated factor X (FXa), and antithrombin deficiency (ATD) is one of the most severe thrombophilic disorders. In this study, we identified nine novel AT mutations and i…